Clearance Summary
Spectra Q received FDA 510(k) clearance under submission number K191109, sponsored by Uzinmedicare Co.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Obstetrics/Gynecology review panel. The statutory decision date of record is 2020-01-22.
- Submission: K191109
- Applicant / Sponsor: Uzinmedicare Co.
- Clearance pathway: Traditional
- Review panel: Obstetrics/Gynecology
- Device class: Class II
- Regulation citation: 21 CFR 884.5160
- Decision date: 2020-01-22
Classification & Regulation
This clearance is catalogued under FDA product code HGX and 21 CFR 884.5160, within the Obstetrics/Gynecology review panel as a Class II device.